EVOKE Plus trial

Study / Research

A GLP-1 trial that did not show improvement in cognition or effect on p-tau217 for Alzheimer's.

Mentioned in 1 video

Videos Mentioning EVOKE Plus trial

407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more

407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more

Peter Attia MD

A GLP-1 trial that did not show improvement in cognition or effect on p-tau217 for Alzheimer's.